Gene therapy trials: a patient pathway.
This article describes ongoing gene therapy trials at University Hospital Birmingham NHS Trust for liver, head and neck and prostate cancer treatment. The authors suggest that this research programme might become an alternative option for patients who have not responded to conventional treatments.
Hull
Diana
D
Clinical Trials Unit, Cancer Research UK, Institute for Cancer Studies, Medical School, University of Birmingham. Diana.Hull@uhb.nhs.uk
Chester
Michelle
M
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001388:Aziridines / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004739:England; D018014:Gene Transfer Techniques / Q000451:nursing*; D006258:Head and Neck Neoplasms / Q000451:nursing / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000451:nursing / Q000628:therapy*; D008297:Male; D018579:Patient Selection; D011355:Prodrugs / Q000008:administration & dosage*; D011471:Prostatic Neoplasms / Q000451:nursing / Q000628:therapy*
D000970:Antineoplastic Agents; D001388:Aziridines; D011355:Prodrugs; C100099:tretazicar